Diabetes symptom relief through a laser based medical device

ABSTRACT

Disclosed are several methods, apparatus, and a system for providing diabetic symptom relief through a laser based medical instrument. In one embodiment, a method includes generating a radiation of a laser-light created by a laser diode of a first medical instrument. In addition, the method includes applying a treatment of the radiation to a portion of a body. The method also includes reducing elevated blood glucose and/or glycosylated hemoglobin levels caused by one or more metabolic diseases such as diabetes. The method further includes providing a relief from the secondary complications of elevated blood glucose levels such as blurred vision, etc., when the treatment is complete.

FIELD OF TECHNOLOGY

This disclosure relates generally to the field of medical instruments,and, in one embodiment, to several methods, a system, and apparatus of alaser based medical instrument for providing diabetic symptom relief.

BACKGROUND

Diabetes affects millions of people each year. There are two types ofdiabetes: type 1 diabetes occurs when the pancreas secretes little or noinsulin; type 2 diabetes occurs when the body produces too littleinsulin or has become resistant to insulin's action. As a result ofeither insulin deficiency or the body's resistance to insulin, the levelof glucose in the bloodstream increases causing hyperglycemia. Leftuntreated, high blood sugar can lead to secondary complications such aselevated blood glycosylated hemoglobin levels (HbAlc), blurred vision,weakness, double vision, cramps, shortness of breath, abdominal pain,leg pain, blindness, nerve damage (neuropathy) and kidney damage.

Various oral and injectable medications are currently used to managetype 1 and type 2 diabetes. Unfortunately, prolonged use of oralmedications and/or insulin injections can have undesirable side-effects.For example, oral medications that increase insulin production include:Januvia, which may cause upper respiratory tract infection, sore throatand headache; and Sitagliptin, which has been associated with severeinflammation of the pancreas. In addition, Sulfonylureas such asGlipizide may cause low blood sugar, nausea and weight gain. Insulininjections are also used to treat severe diabetic conditions. However,long term effects of insulin injection treatment are unpredictable andcan lead to further complications in some individuals.

SUMMARY

Disclosed are several methods, apparatus, and a system for providingdiabetes symptom relief through a laser based medical instrument. In oneaspect, a method includes generating a radiation of a laser-lightcreated by a laser diode of a first medical instrument. In addition, themethod includes applying a treatment of the radiation to an applicationpoint affected by insulin deficiency or resistance associated withdiabetes. The method also includes reducing elevated blood glucoselevels (hyperglycemia) caused by either type 1 diabetes or type 2diabetes. The method further includes providing a relief from secondarycomplications caused by diabetes, when the treatment is complete. Inseveral embodiments, the medical instrument may be a laser therapydevice.

In several embodiments the treatment or therapy administered by themedical instrument to treat a biological medium may be referred to as,but is not limited to, low-level laser therapy (LLLT), laserbiostimulation, laser irradiation, laser therapy, low-power laserirradiation, or low-power laser therapy. In several embodiments, themedial instrument may provide laser therapy or laser treatment to thebiological medium.

In addition, the method may include adjusting one or more of a pulsationpower, a pulsation frequency, and/or a pulsation duration of theradiation to provide the treatment. The wavelength of the radiation maybe adjusted by using different laser diodes. The method may includecoordinating a delivery of a soliton wave when the radiation of thelaser-light is applied. The method may also include coupling the firstmedical instrument to a second medical instrument. The method mayfurther include generating a first soliton wave through the firstmedical instrument at a first wavelength and at a first frequency. Themethod may also include generating a second soliton wave through thesecond medical instrument at a second wavelength and at a secondfrequency. In addition, the method may include coordinating a deliveryof the first soliton wave and the second soliton wave on a biologicalmedium through an algorithm that controls delivery of laser and diodelight of the first medical instrument and the second medical instrument.The method may also include adjusting one or more of the pulsationpower, the pulsation frequency, and the pulsation duration of theradiation to provide an additional treatment with a custom mode and/orwith a preconfigured mode. The radiation in specific may be provided toone or more application points on a biological medium.

In addition, the method may include authenticating a medical instrumentbased on an identifier associated with the medical instrument using aprocessor. The method may include authenticating a user of the medicalinstrument based on a password using the processor. In addition, themethod may include generating a graphical representation of the medicalinstrument. The method may also include providing a set of rulesassociated with the medical instrument based on the identifier and theuser. The method may further include generating a custom mode ofoperation of the medical instrument based on a response of the user. Themethod may also include creating a name associated with the custom modeof operation. In addition, the method may include automaticallyprogramming the medical instrument based on the custom mode. The methodmay also include sharing the custom mode with other users and othermedical instruments based on the set of rules and a preference of theuser. The disease associated with the hyperglycemia may be diabetes. Inaddition, the method includes treating a diabetes patient with highblood glucose levels by laser-light radiation, administered every otherday for 18-60 day durations.

In addition, the method may include adjusting frequency and pulsationduration of the laser-light radiation to provide a treatment with apreconfigured mode.

In another aspect, the method includes generating a radiation of alaser-light created by a laser diode. In addition, the method includesapplying a treatment of the radiation to a portion of a body part. Themethod also includes reducing a condition that includes reduction in ablood glucose level, a blood glycosylated hemoglobin level (HbAlc), andin turn reducing the secondary complications of diabetes such as blurredvision, weakness, double vision, cramps, shortness of breath, abdominalpain and leg pain. The method further includes providing a relief fromthe secondary complications when the treatment is complete. In addition,the method may include providing a relief from diabetes.

In yet another aspect, the method includes generating a radiation of alaser-light created by a laser diode. In addition, the method includesmonitoring the radiation. The method also includes applying a treatmentof the radiation to a portion of a body part. The method furtherincludes reducing hyperglycemia in diabetes. In addition, the methodincludes providing a relief from the condition when the treatment iscomplete. The method may also include using a warning Light EmittingDiode (LED) to monitor the radiation.

The methods disclosed herein may be implemented in any means forachieving various aspects, and may be executed in a form of amachine-readable medium embodying a set of instructions that, whenexecuted by a machine, cause the machine to perform any of theoperations disclosed herein. Other features will be apparent from theaccompanying drawings and from the detailed description that follows.

BRIEF DESCRIPTION OF THE DRAWINGS

Example embodiments are illustrated by way of example and are notlimited to the figures of accompanying drawings, in which likereferences indicate similar elements and in which:

FIG. 1 illustrates a patient and a doctor diagnosing the patient,according to one or more embodiments.

FIG. 2A-C illustrates a treatment being provided to a part of patientbody suffering from diabetes, according to an example embodiment.

FIG. 3A-C illustrates several application points in a human body fortreating diabetes.

FIG. 4 illustrates a system view that illustrates medical instrumentsbeing communicatively coupled and coordinated through a data processingsystem for treatment of the patient, according to an example embodiment.

FIG. 5 illustrates a schematic view of a primary instrument, accordingto one embodiment.

FIG. 6 illustrates an alternative system comprising the medicalinstruments that are communicatively coupled and coordinated through adata processing system for treatment of the patient, according toanother embodiment.

FIG. 7 illustrates a use of the medical instruments used for providingtreatment to a biological medium, according to one embodiment.

FIG. 8 is a process flow illustrating a treatment being provided throughthe medical instruments, according to one or more embodiments.

FIG. 9 is a process flow detailing the operations involved in a methodof laser therapy, according to one or more embodiments.

FIG. 10 is a schematic view of a medical instrument, according to one ormore embodiments.

FIG. 11 is a schematic view of a probe device, according to one or moreembodiments.

FIG. 12 is a system view illustrating a mode server communicatinginformation associated with a mode to a medical instrument(s) through aclient device(s) via a network, according to one or more embodiments.

FIG. 13 is a user interface view providing a platform for medicalinstrument users to interact with other medical instrument users in anonline social community environment, according to an example embodiment.

FIG. 14 is table showing the common symptoms exhibited by diabetic type1 or type 2 patients.

FIG. 15 shows low-level laser treatment for some of the symptomsexhibited by diabetic type 1 or type 2 patients. The table also showsdifferent modes of treatment with varied wavelength of the low-levellaser for treating a particular symptom.

Other features of the present embodiments will be apparent fromaccompanying drawings and from the detailed description that follows.

DETAILED DESCRIPTION

Example embodiments, as described below, may be used to provide severalmethods, a system, and apparatus of a laser based medical instrument forreducing hyperglycemia in diabetic patients. Although the presentembodiments have been described with reference to specific exampleembodiments, it will be evident that various modifications and changesmay be made to these embodiments without departing from the broaderspirit and scope of the various embodiments.

FIG. 1 illustrates a patient 100 and a doctor 102 diagnosing the patient100, according to one or more embodiments. The patient 100 may be anindividual suffering from very high levels of glucose and HbAlc in theirblood. In one embodiment, the patient 100 may be suffering fromdiabetes. Glucose can act as an oxidizing agent in glycation breakdowndepending on the composition of surrounding molecules. Glucose reactsnon-enzymatically with protein amino groups to initiate glycation, theearly stage of the Maillard reaction, leading to crosslinking andbrowning of the proteins via the formation of advanced glycation endproducts (AGEs). The AGEs are responsible for various biochemicals intissues which can lead to development of several complications indiabetes including, but not limited to, neuropathy, angiopathy.

The monocyte macrophage plays an important role in this process both byremoving the senescent molecules that have accumulated AGEs over timeand by initiating the steps that lead to new protein synthesis andtissue remodeling. By regulating the amounts of active macrophages vialaser-light radiation, it is possible to regulate blood glucose and AGEbreakdown and prevent development of complications from diabetes. Thedoctor 102 may diagnose the patient 100 to generate a diagnosis report104. The diagnosis report 104, inter alia may include blood level ofglucose, blood level of glycosylated hemoglobin, blurred vision,weakness, double vision, cramps, shortness of breath, abdominal pain andleg pain in the patient's body. The doctor 102 may use the diagnosisreport 104 to determine a type of treatment for the patient 100. In oneor more embodiments, the patient 100 may choose a treatment using a setof substantially similar medical instruments described herein.

FIG. 2A-C illustrates a treatment being provided to application pointsfor a diabetic patient 100 according to an example embodiment. Inparticular, FIG. 2A-C illustrates a medical instrument 200A-B, a set oflaser diodes 202, a radiation 204, an application point 208A-C,according to one or more embodiments.

In an example embodiment, as described in FIG. 1, the patient 100 may besuffering from diabetes. In one or more embodiments, treatment may beprovided by providing radiation to the application point 208A-C usingthe medical instruments 200A-N. In an example embodiment, FIG. 2A-Cillustrates treatment being provided to the affected area 208A-C of thepatient's various application points 208. Application points asdescribed herein may include proprioceptive points, acupoints, pressurepoints and other points. The treatment may be provided by delivering theradiation 204 on the application point 208A-C. The radiation 204 asdiscussed herein may be an energy that is transmitted in the form ofsoliton waves. The soliton waves may be a self-reinforcing solitary wavethat maintains its shape while traveling at a constant speed. In one ormore embodiments, the radiation 204 may be generated from a laser-lightgenerated by the set of laser diodes 202 of the medical instruments200A-B. The medical instruments 200A-B may generate the soliton wavesfrom the one or more substantially planar laser diode(s) 202. The laserdiode(s) 202 may be a semiconductor device(s) that produces coherentradiation in which the waves are all at the same frequency and phase. Inone or more embodiments, the laser diodes of the medical instrument200A-N may be configured to adjust one or more of a pulsation power, apulsation frequency, and a pulsation duration of the radiation toprovide the treatment. In one or more embodiments, the pulsation power,a pulsation frequency, and a pulsation duration of the laser diodes 200may be adjusted as per requirements. The requirements may vary as pertherapeutic condition of a patient.

In one or more embodiments, the radiation 204 may be delivered on areas(e.g., application points) affected by diabetes (e.g., type 2) to reduceblood glucose and HbAlc. The radiation 204 being transmitted in a formof the soliton waves may be generated at a particular frequency. In oneor more embodiments, the pulsation frequency and the pulsation durationof the radiation 204 may be adjusted to provide treatment based onrequirements and condition of the patient 100. In one or moreembodiments, the pulsation frequency and the pulsation duration of theradiation 204 may be adjusted based on a custom mode. In one or moreembodiments, the medical instrument 200A-B may be configured to generatea radiation at a wavelength of approximately ˜660 nm or ˜808 nm. In yetanother embodiment, the medical instrument 200 A-B may be configured togenerate radiation with several wavelengths between 480 nm to 940 nm. Inone or more embodiments, delivery of soliton waves may be coordinatedwhen the radiation 204 of the laser-light is applied.

In an example embodiment, FIG. 2A illustrates providing treatment to theapplication point area 208A in front of the left ear over the TMJ of thepatient 100. FIG. 2B illustrates delivering the radiation 204 on theaffected area 208B of the application point. The medical instrument200A-B may generate the radiation 204 to be delivered to an applicationpoint located in the 208A. FIG. 2B illustrates delivery of the radiation204 to an application point located just below the navel point 208B.FIG. 2C illustrates delivery of the radiation 204 to an applicationpoint located in an elbow crease 208C. The delivery of the radiation 204to the application point may be for a specific duration of time and fora suggested course. For example, the treatment for diabetes type 2 maybe for one minute, repeated three times. In one or more embodiments, theduration of the treatment (providing radiation) may be pre-determinedbased on a mode or based on the suggestion provided by the doctor 102.In one or more embodiments, the medical instrument 200A-B (or othermedical instruments 200A-N) may be configured to radiate for a specificduration (and specified number of times or cycles) for a specifictreatment based on a medical condition. Delivering the radiation 204 mayreduce high blood glucose levels in a diabetic patient. Relief may beobtained after reduction of blood glucose levels when the treatmentprocess is completed (e.g., when the delivery of the radiation 204 forspecific period is completed).

FIG. 2A-C illustrates delivery of the radiation 204 by the medicalinstrument 200A-B on the application point of the patient's body parts208, according to an example embodiment. In one or more embodiments, themedical instrument 200A-B may optionally include an etched warningindicator 218. In one or more embodiments, the etched warning indicator218 may be used to monitor the radiation 204. When the instrument isemitting radiation the etched warning indicator 218 may illuminate. Theetched warning indicator 218 may emit light for a duration suggested forthe treatment, thereby indicating a user to use the medical instrument200A-B on the application points for the suggested amount of time.

It has to be noted that the etched warning indicator 218 may emit lightup to a certain amount of time for which the etched warning indicator218 is configured for the duration of the treatment. In one embodiment,once the duration of treatment elapses, the etched warning indicator 218stops emitting light and the medical instrument 200A-B stops emittingradiation.

FIG. 3A-C illustrates several application points on a human body. Theapplication points 300 _(1-N) are illustrated in FIG. 3A-C. For thediabetic patient, the points as outlined in the figures may be withinthe following locations: just in front of the left ear over the TMJ;under the angle of the jaw with the laser pointed upwards at a 45 degreeangle; two finger widths below the collar bone and three finger widthsfrom the arm pit; over the neck below the Adams apple, over the “V”where the collar bones meet; over the left kidney in the small of theback approximately one hand width above the belt and one hand width tothe left of the spine; and a spot hand width below and in line with thenavel and extreme edge of the elbow crease. Treatment may be applied tovarious application points in the body.

The brain derives much of its feedback information from a process calledproprioception. The proprioception is a stimulation of a body tissue toactivate protective mechanisms. There are other points such asacupuncture points (also called as acupoints) which are located acrossanatomy that affect a specific organ. Application points as describedherein may include proprioceptive points, acupoints, pressure points andother points that may be used as treatment points using the medicalinstruments. By activating the application points with the medicalinstrument (e.g., Q1000® by 2035, Inc.™), the body responds through itsvoluntary nervous/muscular system, but in an involuntary way. TheCentral Nervous System is a network of nerve fibers that extendeverywhere throughout the human body. These nerve fibers send signals tothe organs and muscles, and the nerves and muscles responds to thesesignals by sending response signals back to the brain. All of thissignaling occurs automatically and is not under an individual'sconscious control. When the laser (e.g., Q1000® by 2035, Inc.™) isapplied to these application points for approximately one minute, thesemuscles release and the application signal to the brain changes, whichin turn positively affects the Sympathetic and Parasympathetic divisionsof the Autonomic Nervous System. Releasing the Sympathetic divisioncontrols stress and subsequently the organ functions improve and thepancreatic function may improve the production of insulin.

Proprioception may be defined as the unconscious perception of movementspatial orientation arising from stimuli within the body itself. It isalso the body's way of protecting itself. Proprioception directlyaffects the autonomic nervous system. The autonomic nervous systemregulates organ function by coordinating sympathetic and parasympatheticsignals. When the sympathetic nervous system is stimulated, there may beincreased body activity, increased stress, increased blood pressure,increased heart rate and increased breathing rate. When these areasincrease, there may be a simultaneous decrease of glandular, stomach andintestinal function. The body becomes more acidic, goes into a state ofoxidation, stress may be increased, and disease may be eminent. Ifactivity in the parasympathetic nervous system increases by stimulationof the body's application points, the opposite happens. The heart andbreathing rates slow, blood pressure and acid levels normalize, theremay be an increase in the glandular and gut activity, the body reservesincrease, and there may be less disease. By balancing the sympatheticand parasympathetic nervous systems there may be less disease.

Instrument

FIG. 4 is a system view that illustrates medical instruments 200A-Nbeing communicatively coupled and coordinated through a data processingsystem 412 for treatment of the patient 100, according to an exampleembodiment. In particular, FIG. 4 illustrates the medical instruments200A-N, interfaces 402-404, radiations 408A-N, the data processingsystem 412, a processor 414, and the patient 100, according to oneembodiment.

In one or more embodiments, the medical instruments 200A-N may not becoupled to the data processing system during treatment. In one or moreembodiments, the medical instruments 200A-N described herein areportable and hand-held devices. The medical instruments 200A-N may becommunicatively coupled to each other and to the data processing system412 through the interface(s) 402-404. The interface(s) 402-404 may serveas a communication link between the medical instruments 200A-N. In oneor more embodiments, there may be any number of interfaces to enablecoupling of medical instruments 200A-N. The aforementioned dataprocessing system 412 may be a computing device (e.g., computer) thatincludes the processor 414. In one or more embodiments, the dataprocessing system 412 may be used for communicating mode information tothe medical instruments 200A-N through the interfaces 402-404.

In one or more embodiments, the medical instruments 200A-N coupled toeach other through the interfaces 402-404 may generate the radiations408A-N individually or in coordination. In one or more embodiments, theradiation 408A-N (soliton waves) may be generated from the laser-lightgenerated by the laser diodes of the medical instruments 200A-N. In oneor more embodiments, the radiations 408A-N may be generated incombination and coordination or individually. In another embodiment, analgorithm that coordinates the delivery of laser-light may be controlledby the medical instruments 200A-N. The algorithm may be designed basedon the requirement of a medical procedure. It should be noted that thedelivery of the radiations is possible even without coordination.

In an example embodiment, each of the medical instruments 200A-N maygenerate the radiations 408A-N at preconfigured modes. In one or moreembodiments, each of the medical instruments 200A-N may be configuredindividually to generate the radiations 408A-N at specified frequencies.In one or more embodiments, medical instruments 200A-N may becommunicatively coupled to the data processing system 412 to communicatenew modes to the medical instruments 200A-N. The data processing system412 may communicate new modes to the medical instruments 200A-N.

There may be a variety of operational modes for operating the medicalinstruments 200A-N. The operational modes may be based on a suggestedform of a treatment. In one or more embodiments, the medical instruments200A-N may coordinate among each other synchronously, asynchronously, orin a pattern to provide laser therapy. The radiations 408A-N generatedmay be delivered on biological mediums (e.g., application points in ahuman body) based on a procedure of medical treatments. In anotherembodiment, the medical instrument 200A may be used by a patient fortreatment.

In an example embodiment, the radiations 408A-N may be generated bycanceling a nonlinear effect and a dispersive effect in a region betweenan emitting region of the medical instrument 200A-N and the biologicalmedium. The dispersive effect may be a dispersion relationship (e.g.,variation of wave propagation with wavelength or frequency of a wave)between a frequency and a speed of the soliton wave. In one or moreembodiments, the medical instruments 200A-N may include primary deviceand probe devices. The primary device (e.g., the medical instrument200A) is explained in FIG. 5. The medical instrument 200B may beexplained in detail in FIG. 11.

FIG. 5 is a schematic view of a primary instrument 502, according to oneembodiment. In particular, FIG. 5 illustrates the primary instrument 502and an identification card 504, according to one embodiment. In one ormore embodiments, the identification card 504 may be used as the modecard, where the modes can be stored on the medical instrument 200A. Theidentification card 504 may activate the modes stored on the medicalinstrument 200A.

In an example embodiment, the medical instrument 200A may be the primaryinstrument 502. The primary instrument 502 as described herein mayinclude the identification card 504.

In one or more embodiments, the identification card 504 of the medicalinstrument 200A may be used for selecting an operational mode of themedical instrument 200A. The identification card 504 coupled to theprimary instrument 502 may be removable by a user of the medicalinstrument 200A. The operational modes may be associated with asuggested form of a medical treatment. There may be a variety ofoperational modes for a treating of a particular ailment. A patient 100may choose a best mode of treatment based on his condition of thedisease. The patient 100 may choose a best operational mode for thetreatment using the medical instrument 200A.

In one or more embodiments, the operational modes may be stored onmedical instrument 200A, and the best operational mode may be activatedby the identification card 504. The identification card 504 may beprogrammed using an appropriate device. Furthermore, the identificationcard 504 may be reprogrammed based on a prescription associated with thetherapeutic condition of the patient 100. In one or more embodiments,the patient 100 may decide on a custom mode for providing an additionaltreatment by the medical instrument. In one or more embodiments, acustom mode of operation of the medical instruments 200A-N may begenerated and/or determined based on a response of the user. The custommode that may be suggested by the instrument maker and may be programmedinto the identification card 504. The identification card 504 may becommunicatively coupled to the primary instrument 502 through a portdesignated for that purpose. The primary instrument 502 may thengenerate a radiation based on the mode that is loaded from theidentification card 504. In one or more embodiments, a name associatedwith the custom mode of operation may be created and the configurationassociated with the custom mode may be stored in the data processingsystem 412 for future treatments.

In alternate embodiments, the identification card 504 may be madespecific to one therapeutic condition (e.g., diabetes). In one or moreembodiments, the operational modes of the medical instruments 200A-N maybe provided from the data processing system 412 thereof. In one or moreembodiments, the custom mode may be shared with the other medicalinstruments based on a set of rules and preferences of the user and/orthe doctor 102. In one or more embodiments, the custom mode may beshared by communicating the custom mode to the data processing system412 and applying the custom mode to the other medical instrumentsthrough the data processing system 412.

In one or more embodiments, the medical instrument 200A may be used fortreatment in general conditions. In one or more embodiments, where thereis a requirement of directed, high-power dosage in a narrow region of abiological medium, the second medical instrument 200B, for example, maybe a probe device. The probe device may be explained in detail in FIG.11. The primary device or the medical instrument 200A may be explainedin detail in FIG. 10.

FIG. 6 is an alternative system comprising the medical instruments200A-N that are communicatively coupled and coordinated through the dataprocessing system 412 for treatment of a patient 100, according toanother embodiment. In particular, FIG. 6 illustrates the patient 100,the medical instruments 200A-N, a device hub 602, the radiations 408A-N,the data processing system 412, and the processor 414, according to analternate embodiment.

FIG. 6 provides an alternative embodiment to the system illustrated inFIG. 4. In an embodiment, the medical instruments 200A-N may becommunicatively coupled to the data processing system 412 through thedevice hub 602. The device hub 602 may be a device that is used toconnect the medical instruments 200A-N to the data processing system412. In an example embodiment, the device hub 602 may serve as a bridgebetween the medical instruments 200A-N and the data processing system412. Each of the medical instrument 200A-N may be connected to thedevice hub 602. The processor 414 in the data processing system 412 mayprovide modes of treatment to the medical instruments 200A-N through thedevice hub 602. In one or more embodiments, the system as illustrates inthe FIG. 6 may function the same as described in FIG. 4.

FIG. 7 is a schematic view illustrating a use of the medical instruments200A-B for providing treatment to an application point, according to oneembodiment. In particular, FIG. 7 illustrates the biological medium 702,an emitting region 704, an emitting region 706, a mode module 708, and abattery 710, according to one or more embodiments.

In an example embodiment, the radiation 408A may be generated bycanceling a nonlinear effect and a dispersive effect in a first region712 between an emitting region of the medical instrument 200A and thebiological medium. In an example embodiment, the radiation 408B may begenerated by canceling a nonlinear effect and a dispersive effect in asecond region 714 between an emitting region of the medical instrument200B and the biological medium. The dispersive effect may be adispersion relationship (e.g., variation of wave propagation withwavelength or frequency of a wave) between a frequency and a speed ofthe soliton wave.

In an example embodiment, the biological medium 702 described herein maybe a part of a patient's body such as an application point. In alternateembodiments, the biological medium 702 may be an animal or bird or anyother concerned life form affected by the disease. The medicalinstruments 200A-B described herein may be used on the biological medium702 individually or in coordination to provide a radiation to theaffected areas. The emitting region 704 of the medical instrument 200Amay include a set of laser diodes 202 carefully placed and supported bythe associated circuitry to generate a radiation. Similarly, theemitting region 706 of the medical instrument 200B may include a laserdiode(s) to generate a radiation.

The medical instrument 200A may be powered using the battery 710. In analternate embodiment, the medical instrument 200A may also be poweredthrough external sources (e.g., through a power cord). In an exampleembodiment, the battery 710 may be a lithium-ion rechargeable battery topower the medical instruments 200A. In one or more embodiments, abattery charger may be used to charge the battery 710 of the medicalinstrument 200A. In one or more embodiments, the battery chargingcapability may be provided through an external connector that may servepurposes not limited to battery charging. A power regulator of thebattery 710 (not shown in the figure) may be used to provide stable andaccurate power output to the medical instruments 200A-B. In one or moreembodiments, the power regulator may closely monitor charge current aswell as maximum allowed voltage. In one or more embodiments, the powerregulator may prevent over-charging/over-discharging of the battery 710.The mode module 708 may enable the circuitry of the medical instrument200A to generate a radiation based on a particular operational mode thatis loaded into the medical instrument 200A-B through the identificationcard 504. In one or more embodiments, the medical instruments 200A-N mayoperate at a power level of approximately ˜50 mW or ˜500 mW. In yetanother embodiment the medical instruments 200A-N may use several laserdiodes operating at power levels of approximately ˜5 mW.

The medical instrument 200A-N described herein may be authenticatedbased on an identifier associated with the medical instruments 200A-Nusing the processor 414. In one or more embodiments, the authenticationof the user of the medical instruments 200A-N may be based on a passwordusing the processor 414. In one or more embodiments, a set of rulesassociated with the medical instrument(s) may be provided based on theidentifier and the user.

TABLE 1 Effect of using laser based medical instrument treatment onblood glucose levels in Type 2 Diabetic patients: After StartingTreatment blood Blood Patient Type of Treatment Glucose Glucose NumberAge Diabetes duration Medication level level 1 76 years Type 2 60 daysOral Over 250 mg/dL 121 mg/dL hypoglycemic drug 2 70 years Type 2 60days Prednisone 260 mg/dL 120 mg/dL  3. 58 years Type 2 45 days Oral 220mg/dL 110 mg/dL hypoglycemic medication

Table 1 shows clinical trials result in reduction of blood glucoselevels in type 2 diabetic patients with various treatment periodsranging from 45-60 days. The treatment with a laser based medical devicewas done along with suggested oral medications. None of the medicationswere discontinued during the treatment period. Significant drops inblood glucose levels were observed after set period of treatment days.

TABLE 2 Effect of using laser based medical instrument treatment onusage of units of insulin requirement levels in Type 1 Diabetic patient:Units of Insulin Units of Insulin Type of required before required afterPatient number Age Diabetes treatment treatment 1. 15 years Type 1 22 2

Table 2 shows the beneficial effects of using a laser based medicalinstrument, reducing the required number of insulin injections from 22units to 2 units per day in a 15 year old patient having type 1 diabetesfor 18 days. The suggested medication was not discontinued during thelaser based medical instrument treatment.

FIG. 8 is a process flow illustrating a treatment being provided throughthe medical instruments 200A-N, according to one or more embodiments. Inoperation 802, the radiation 204 of a laser-light created by the laserdiodes 202 may be generated. In operation 804, a pulsation frequencyand/or a pulsation duration of the radiation 204 may be adjusted toprovide a treatment. The wavelength of the radiation may be adjusted byusing different laser diodes. In one or more embodiments, the pulsationfrequency, the pulsation power, and/or the pulsation duration of theradiation 204 may be also be adjusted to provide a treatment with acustom mode. In operation 806, a delivery of a soliton wave may becoordinated. In operation 808, the radiation 204 may be monitored. Inone or more embodiments, the etched warning indicator 218 may be used tomonitor the radiation 204. In operation 810, a treatment of theradiation 204 may be applied to a portion of a body part (e.g., asillustrated in FIG. 3). In operation 812, elevated glucose level in theblood may be reduced. In operation 814, a relief from the condition maybe provided when the treatment is complete. The first region 712 mayillustrate the radiation area of the medical instrument 200A (e.g., asillustrated in FIG. 7). The second region 714 may illustrate theradiation area of the medical instrument 200B (e.g., as illustrated inFIG. 7).

The treatments described herein may be provided to the patient 100 forreducing hyperglycemia caused due to ailments such as diabetes. Theaforementioned treatments may reduce the HbAlc. In addition, theaforementioned treatments may provide a relief from diabetes. Also, inone or more embodiments, operational modes may be provided to themedical instrument over a network as illustrated in FIG. 12. Inaddition, the modes, information, etc., may also be exchanged over anonline social community as illustrated in an example embodiment in FIG.13.

FIG. 9 is a process flow detailing the operations involved in a methodof laser therapy, according to one or more embodiments. In operation902, one or more substantially planar laser diode(s), each configured tolase at a wavelength when driven, may be provided to form a medicalinstrument. In one or more embodiments, a number of substantially planarlaser diodes may be arranged in a pre-determined configuration to form asubstantially planar laser diode array. In one or more embodiments, thesubstantial planarity, along with a symmetrical pre-determinedconfiguration, may provide for a symmetrical combination of the outputbeams from the number of substantially planar laser diodes to form ahighly directed resultant beam.

In one or more embodiments, the soliton waves may be generated from theone or more substantially planar laser diode(s). In one or moreembodiments, end minors of the one or more substantially planar laserdiode(s) may be replaced with anti-reflection coatings, and when the oneor more substantially planar laser diode(s) are driven, the opticalfield evolution in the laser diode(s) may be modeled by using twocoupled differential equations (example Equations 1 and 2) as:

$\begin{matrix}{{\frac{\partial\varphi}{\partial z} = {{{\mathbb{i}}\frac{\partial^{2}\varphi}{2{\partial x^{2}}}} + {\left( {{{- {\mathbb{i}}}\; h\; N} + \left( {N - 1} \right) - \alpha} \right)\varphi}}},} & (1) \\{{{D\frac{\partial^{2}N}{\partial x^{2}}} = {{- \pi} + N + {BN}^{2} + {CN}^{2} + {\left( {N - 1} \right){\varphi }^{2}}}},} & (2)\end{matrix}$

where φ may be the optical field solution, i=√{square root over (−1)}, xand z the spatial coordinates, h the Henry factor, α the internal loss,N the normalized carrier density

$\left( {{N = \frac{N^{\prime}}{N_{tr}^{\prime}}},} \right.$N′ being the carrier density, N′_(tr) and being the transparency carrierdensity), D the carrier diffusion coefficient, π the current pumpingcoefficient, B the spontaneous recombination coefficient, and C theAuger recombination rate. Here, a linear dependence of the inducedrefractive index and gain on the carrier density N′ may be assumed.

In one or more embodiments, neglecting carrier diffusion in the zdirection, and assuming small diffusion, B=0, and C=0, a generalizedcomplex Ginzburg-Landau equation may be obtained from Equations 1 and 2as example Equation 3:

$\begin{matrix}{{\frac{\partial\varphi}{\partial z} = {{{{\mathbb{i}}\left( {\frac{1}{2} - {\mathbb{i}\beta}} \right)}\frac{\partial^{2}\varphi}{\partial x^{2}}} + {\left( {{\frac{\pi - 1}{1 + {\varphi }^{2}}\left( {{{- {\mathbb{i}}}\; h} + 1} \right)} - {{\mathbb{i}}\; h}} \right)\varphi} - {\alpha\varphi}}},} & (3)\end{matrix}$where β may account for the transverse carrier diffusion.

In one or more embodiments, soliton wave solutions of the formφ(x)e^(iλz) may be numerically obtained. In one or more embodiments,depending on the arrangement of the number of substantially planar laserdiodes, constructive interference of the outputs of the number ofsubstantially planar laser diodes may lead to a resultant soliton waveof high amplitude. In one or more embodiments, the resultant solitonwave output may have an amplitude several times higher than anon-soliton wave resultant beam.

In operation 904, the resultant beam may be directed on a biologicalmedium to impart energy to the biological medium (e.g., humans). In oneor more embodiments, the resultant beam may be directed on a portion ofthe human body to treat conditions such as diabetes. In one or moreembodiments, in operation 906, a mode of operation of the medicalinstrument may be altered upon removal of the identification card 504 ofthe medical instrument. In one or more embodiments, the identificationcard 504 may be therapeutic condition specific (e.g., diabetes), and theinsertion of a new identification card into the medical instrument mayresult in the medical instrument operating solely in modes of operationspecific to the therapeutic condition. In other words, access to modeinformation is restricted to modes of operation specific to thetherapeutic condition.

In one or more embodiments, altering the mode of operation of themedical instrument upon removal of the identification card, as inoperation 906, may involve substituting an identification card withanother identification card. In one or more embodiments, oneidentification card may be specific to one therapeutic condition (e.g.,diabetes), and the other identification card may be specific to anothertherapeutic condition (e.g., diabetes).

In one or more embodiments, a mode of operation may include one or moresegments, where a segment includes a time of pulsation of the one ormore substantially planar laser diode(s) and a frequency of pulsation ofthe one or more substantially planar laser diode(s). For example, onesegment may include pulsing a laser diode at 50 Hz for 20 seconds, andanother segment may include pulsing a laser diode at 10 Hz for 30seconds. In one embodiment, a mode may consist of up to 250 differentsegments.

FIG. 10 is a schematic view of a medical instrument 1000, according toone or more embodiments. The medical instrument 1000 may in specificdescribe a schematic representation of the medical instrument 200A andthe primary instrument 502. In one or more embodiments, the medicalinstrument 1000 may include a controller 1002 to control operationsfundamental to the working of the medical instrument 1000. In one ormore embodiments, the controller 1002 may include a permanent memory(e.g., flash memory) to store firmware associated with controlling themedical instrument 1000. In one or more embodiments, modes of operationmay internally be set in the firmware. In one or more embodiments, thecontroller 1002 is interfaced with a battery charger 1012 to charge abattery (e.g., internal battery) of the medical instrument 1000. In oneor more embodiments, the battery charging capability may be providedthrough an external connector 1008 that may serve purposes not limitedto battery charging.

In one or more embodiments, the external connector 1008 may be amulti-pin and multi-use external connector that may also be used toprogram the internal controller of the medical instrument 1000 (e.g.,controller 1002), to calibrate constituent laser diodes 1030, to coupleother external compatible devices (e.g. another medical instrument 1000,a probe version of the medical instrument 1000, a computer device, apersonal digital assistant (PDA)) and/or to perform diagnostics of themedical instrument 1000.

In one embodiment, the medical instrument 1000 may be powered by alithium-ion rechargeable battery placed in an inside thereof. Here, thebattery charger may plug into the medical instrument 1000 through theexternal connector 1008, and may closely monitor charge current as wellas maximum allowed voltage. In one or more embodiments, the battery maybe supplied with a safety circuitry to preventover-charging/over-discharging of the battery. In one or moreembodiments, constituent components of the medical instrument 1000 maybe powered during charging of the battery, but user interaction with themedical instrument 1000 may not be possible.

In one or more embodiments, the controller 1002 may be interfaced withan external memory 1010 to enable the medical instrument 1000 to recorddata indicating a diagnostic requirement of the medical instrument 1000.In one or more embodiments, the recorded data may be useful in enablingservicing of the medical instrument 1000. For example, correctivediagnostics may be performed on the medical instrument 1000 by servicepersonnel following a return of the medical instrument 1000 by a user.In one or more embodiments, the external memory 1010 may be anon-volatile memory such as an Electrically Erasable ProgrammableRead-Only Memory (EEPROM).

In one or more embodiments, the medical instrument 1000 may be providedwith a user button 1014 (shown in FIG. 10 as turning on the controller1002) to simplify operations thereof. In one embodiment, the user button1014 may serve as both the power ON/OFF button and the mode selectionbutton.

In one or more embodiments, the medical instrument 1000 may be providedwith a speaker 1016 (shown in FIG. 10 as being controlled by thecontroller 1002) to generate audible alerts as well as indicate thepressing of the user button 1014. In one or more embodiments, theaudible alerts may indicate one or more of an operational status of themedical instrument 1000, a beginning of a mode of operation, a beginningof a segment, an end of a mode of operation, and an end of the segment.In one or embodiments, all audible alerts may be muted by the userduring use of the medical instrument 1000.

In one or more embodiments, to enhance serviceability of the medicalinstrument 1000, a real-time clock 1018 (shown in FIG. 10 as beinginterfaced with the controller 1002) may be implemented in the medicalinstrument 1000. In one or more embodiments, data recorded in theexternal memory 1010 may always be tagged with a current date and timeat the time of recording. In one or more embodiments, this may enable ahistory of use of the medical instrument 1000 to be tracked. Forexample, when a medical instrument 1000 is returned to the servicepersonnel, the service personnel may be better equipped to understandproblems associated with the functioning of the medical instrument 1000.

In one or more embodiments, the medical instrument 1000 may be equippedwith one or more LEDs 1020 and a display 1022 (e.g., seven segmentdisplay) that serve as user indicators. In FIG. 10, the LEDs 1020 andthe display 1022 are shown as being controlled by the controller 1002.In one embodiment, the operational state of the medical instrument 1000may be indicated with an LED emitting green light that may turn redduring a power down. Here, another LED may be provided to indicatebattery state and battery charging. For example, if the light emitted bythis LED turns yellow during normal operation, it may be indicative of alow power level of the battery. The battery may then need to be charged.The LED may emit red light in a blinking state until charging may becomplete, following which the LED may continue to emit green light. Inone or more embodiments, the display 1022 may indicate modes that areloaded onto the medical instrument 1000, and, in one embodiment, themodes may be indicated on the display as 0-9. Here, the user may selecta mode using the mode selection feature of the user button 1014.

In one or more embodiments, one of the purposes of the controller 1002may be to control the laser diodes 1030 through laser drivers 1026thereof. In one or more embodiments, the controller 1002 may control thepower level of the laser diodes 1030, and also the flashing of the laserdiodes 1030. In addition, in one or more embodiments, the controller1002 may monitor a light sensor 1024 that measures the ambient lightoutside the medical instrument 1000. This measurement may be used tocontrol the light intensity of the user indicator LEDs 1020.

In one or more embodiments, the controller 1002 may have the ability tosense the operating current of each laser diode 1030 (see the currentsensor 1028 in FIG. 10), which may be used to deactivate laser diodes1030 that may have failed. In one or more embodiments, this may ensuresafety of operation of the medical instrument 1000. In one or moreembodiments, current may also be sensed during calibration of themedical instrument 1000 to ensure proper operation of the laser diodes1030. In one or more embodiments, a power management circuitry of thelaser diodes 1030 may be controlled by the controller 1002. In one ormore embodiments, infrared light may also be emitted from the infraredLEDs 1040.

In one or more embodiments, the medical instrument 1000 may also includea number of infrared LEDs 1040 (shown as being controlled in FIG. 10 bythe controller 1002) to emit infrared light during a duration of a modeof operation. In one or more embodiments, the infrared LEDs 1040 mayoperate in conjunction with one or more of the visible LEDs 1020.

In one or more embodiments, the controller 1002 may monitor atemperature sensor 1032 to obtain accurate values of the temperatures ofthe laser diodes 1030. In one or more embodiments, variations oftemperature of the laser diodes 1030 may also be tracked.

In one or more embodiments, the medical instrument 1000 may include areset controller 1006 to monitor a reset button. For example, when auser depresses the reset button and holds the reset button for, say, 5seconds, the reset controller 1006 may send a reset signal to thecontroller 1002 to reset the medical instrument 1000. Here, 5 seconds isthe threshold time period, and if a user presses the reset button for atime period exceeding the threshold time period, the medical instrument1000 may be reset.

In one or more embodiments, when the medical instrument 1000 is turnedON and is in an idle state, an LED 1020 indicating power may emit greenlight. In one or more embodiments, a shut off timer may be startedinternally to turn the medical instrument 1000 off in case of inactivity(e.g., no further pressing of buttons) for a time period exceedinganother threshold time period.

In one or more embodiments, the medical instrument 1000 may bepre-programmed (e.g., by the manufacturer) with several operationalmodes. In one or more embodiments, the modes may be pre-programmed withthe duration of treatment for a therapeutic condition, and the specificfrequencies the medical instrument 1000 may be operating at.

In one or more embodiments, where there is a requirement of directed,high-power dosage in a narrow region of a biological medium, the secondmedical instrument 200B, for example, may be a probe device (asillustrated in FIG. 11).

FIG. 11 is a schematic view of a probe device 1100, according to one ormore embodiments. The probe device 1100 may be substantially similar to,or the same as, the medical instrument 200B. In one or more embodiments,the probe device 1100 may include a controller 1102 to control allcomponents of the probe device 1100. In one or more embodiments, anoperating program of the controller 1102 may be user-upgraded using anoptional storage card 1108. In one or more embodiments, the optionalstorage card 1108 may be a flash card from which different programs maybe read.

In one or more embodiments, the probe device 1100 includes a powerconnector 1104 through which a battery of the probe device 1100 may becharged. In one or more embodiments, the medical instrument 200A may beused to power the probe device 1100 through the power connector 1104. Inone or more embodiments, the probe device 1100 may include anidentification card 1110. The identification card 1110 may includeinformation regarding types of treatment modes to be activated. Theinformation on the identification card 1110 may be read by controller1102.

In one or more embodiments, the probe device 1100 may include aprogramming connector 1106 through which a programming/calibrationinterface may be provided. In one or more embodiments, the probe device1100 may be calibrated by a manufacturer and/or serviced by servicepersonnel through the programming connector 1106. In one or moreembodiments, a data processing system 412 may be coupled to the probedevice 1100 through the programming connector 1106. In one or moreembodiments, the programming connector 1106 may not be available to auser but only available to the manufacturer and/or service personnel.

In one or more embodiments, an integrated laser driver 1118 may controla laser diode 1116 of the probe device 1100. In one or more embodiments,an operating current of the laser diode 1116 and/or a light output ofthe laser diode 1116 may be monitored to maintain a constant output ofthe laser diode 1116. In one or more embodiments, the laser diode 1116may be calibrated during the manufacturing process and/or the laserdriver 1118 may be configured to handle a range of laser diodes.

In one or more embodiments, LEDs (1114, 1120) may be provided toindicate an operational state of the probe device 1100. A light from anLED 1114 may also indicate that the optional storage card 1108 isproperly inserted and recognized. In another example, a number of LEDs1120 may indicate modes selected and/or progress during boot-up. In oneor more embodiments, a separate LED 1114 may indicate activity of thelaser diode 1116.

In one or more embodiments, in order for corrective diagnostics to beperformed by service personnel and/or operating statistics to beobtained by the manufacturer, a real-time clock 1122 may be provided inthe probe device 1100. In one or more embodiments, the real-time clock1122 may be programmed during manufacturing. In one embodiment, power tothe real-time clock 1122 may be supplied by a coin cell battery of theprobe device 1100.

In one or more embodiments, the controller 1102 may monitor the currentof the laser diode 1116 during operation of the laser diode 1116 througha current sensor 1128. In one embodiment, the current data may be usedin the calibration of the probe device 1100.

In one or more embodiments, a temperature sensor 1112 may be provided inthe probe device 1100 to monitor a temperature of the laser diode 1116in order to ensure safety of operation of the probe device 1100.

In one or more embodiments, when the probe device 1100 is powered up,green light may be emitted from an LED 1120. In one embodiment, when theoptional storage card 1108 is not present, the green LED 1120 may startto blink to indicate the need to insert the optional storage card 1108.In one or more embodiments, upon insertion of the identification card1110 and checking for updates residing in the identification card 1110,modes of operation may be downloaded into the probe device 1100. In oneor more embodiments, modes of operation present on the identificationcard 1110 may be loaded.

In one or more embodiments, user selection of modes of operation may beaccomplished through a user button 1124. In one or more embodiments, theprobe device 1100 may be turned on by a user holding the user button1124 for a time period exceeding a threshold time period of, say, 5seconds. In one or more embodiments, a warning LED 1114 may be providedto indicate a state where a laser diode 1116 operating at a wavelengthoutside the visible spectrum may be used. In one or more embodiments,the probe device 1100 may also be turned off by a user depressing theuser button 1124 for a time period exceeding another threshold timeperiod.

In one or more embodiments, if at any point the identification card 1110is removed, the laser diode 1116 may be turned off, and the probe device1100 may return to a boot-up state thereof.

FIG. 12 is a system view illustrating mode server 1200 communicatinginformation associated with a mode to a medical instrument(s) 200A-Nthrough a client device(s) 1202A-N via a network 1204, according to oneor more embodiments. Particularly, FIG. 12 illustrates the mode server1200, the client device(s) 1202A-N, the network 1204, and the medicalinstrument(s) 200A-N, according to one or more embodiments. It should benoted that the medical instruments described herein the Figure aresubstantially similar or the same as illustrated in previous Figures.Also, the client device(s) 1202A-N described herein may be substantiallysimilar or the same as illustrated in previous figures.

The mode server 1200 may provide different modes of operation for themedical instruments 200A-N via the network 1204. The client device1202A-N may be any computing device (e.g., the data processing system412) that can interface the medical instrument 200A-N for communicatingthe mode of operation to the other medical instrument 200A-N. The modemay control the laser diodes and the LED diodes (not shown in figures)to generate a laser wavelength based on the mode. In one or moreembodiments, the mode may configure the laser diodes and the LED diodesto generate laser at different wavelengths. In one or more embodiments,the client device 1202A-N may include, but is not limited to, acomputer. In one or more embodiments, the client device 1202A-N uponreceiving the information may provide an acknowledgment to the modeserver via the network 1204. In one or more embodiments, the informationassociated with the mode may include, but is not limited to, a modeconfiguration, setting information, and handling instructions. In one ormore embodiments, the mode server 1200 may be supported by a custom modedatabase (not shown in the Figure). The custom mode database may be acentral resource for information associated with the modes. In one ormore embodiments, a custom mode of operation may be configured into themedical instrument 200A-N and the treatment based on the custom mode maybe provided to the user. In one or more embodiments, the custom modeconfigured by the user may be communicated to the mode server 1200through the client device 1202A-N via the network 1204.

FIG. 13 is a user interface view 1354 providing a platform for medicalinstrument users to interact with other medical instrument users in anonline social community environment 1350, according to an exampleembodiment. In one or more embodiments, the users of the medicalinstruments 200A-N may be provided with an online social communityenvironment. The medical instrument users may communicate with othermedical instrument users, doctors, etc., to share their experiences,provide suggestions, etc. An example embodiment illustrates a user pageof the user John Smith. A list of my friends 1302 illustrates a list offriends of the user John Smith, who may be a part of social community1350. In the example embodiment, the user John Smith may have Dr. Lytle,Sam Harmon, and Mellissa Moe as connections. The mode names 1304 mayillustrate names of the modes of operation associated with thetherapeutic conditions (e.g., type 1 or diabetes type 2). The ratings1306 may provide information to other users regarding the opinion of theusers associated with the mode of treatment. The reviews 1308 mayillustrate the number of reviews performed by other users. In one ormore embodiments, the user John Smith may review the modes and provideratings to the associated modes.

A mode creator 1310 may be a link that enables the user of the userinterface (e.g., John Smith) to create a custom mode or to upload a modecreated by the user (e.g., John Smith). A graphical representation ofthe medical instrument 1352 may illustrate a type of medical instrumentfor which a custom mode can be created. In one or more embodiments, adifferent type of medical instrument may be illustrated for which theuser wants to create a custom mode via functions provided in the userinterface (e.g., through graphical buttons, clicks, etc.).

FIG. 14 illustrates the low-level laser treatment of the patient 100 forwound healing 1406, peripheral neuropathy 1402 and extreme hunger 1408.These are some of the symptoms shown in table 1550 used for diseasediagnosis in patient 100 who may be suffering from a diabetes type 1 ortype 2 disease.

FIG. 15 is a tabular view 1550 diabetes type 1 (1502) and type 2 (1506)symptoms. Low-level laser treatment 1504 and 1508 for diabetes type 1and type 2 are shown. The low-level laser treatment can have differenttreatment modes and different wavelengths of lasers for each symptom andmay vary depending on the needs of the patient 100.

Although the present embodiments have been described with reference tospecific example embodiments, it will be evident that variousmodifications and changes may be made to these embodiments withoutdeparting from the broader spirit and scope of the various embodiments.Accordingly, the specification and drawings are to be regarded in anillustrative manner rather than a restrictive sense.

What is claimed:
 1. A method comprising: generating a first soliton wavethrough a laser diode of a first medical instrument at a wavelength ofapproximately 660 nm to 808 nm; generating a second soliton wave througha laser diode of a second medical instrument at a wavelength ofapproximately 660 nm to 808 nm; applying the first soliton wave to afirst application point located over the left kidney of a patientsuffering from Type I or Type II diabetes on the small of the patient'sback, one hand width above the belt and one hand width to the left ofthe spine, for a one minute duration; repeating the application of thefirst soliton wave to the first application point for the one minuteduration two more times in the same day; applying the second solitonwave to a second application point located over the extreme outer edgeof the patient's inner elbow crease, for a one minute duration;repeating the application of the second soliton wave to the secondapplication point for the one minute duration two more times in the sameday; coordinating the application of the first soliton wave and thesecond soliton wave through an algorithm that controls the generation ofthe first soliton wave of the first medical instrument and thegeneration of the second soliton wave of the second medical instrument;and reducing a glycosylated hemoglobin Alc (HbAlc) of the patient as aresult of the application of the first soliton wave and the secondsoliton wave.
 2. The method of claim 1, further comprising: adjusting atleast one of a pulsation power, a pulsation frequency, and a pulsationduration of the first medical instrument and the second medicalinstrument through a controller of the first medical instrument and acontroller of the second medical instrument, respectively.
 3. The methodof claim 1, further comprising: authenticating the first medicalinstrument based on an identifier associated with the first medicalinstrument using a processor; authenticating a user of the first medicalinstrument based on a password using the processor; generating agraphical representation of the first medical instrument; providing aset of rules associated with the first medical instrument based on theidentifier associated with the first medical instrument and the user;generating a first custom mode of operation of the first medicalinstrument based on a response of the user; creating a name associatedwith the first custom mode of operation; automatically programming thefirst medical instrument based on the first custom mode; sharing thefirst custom mode with other users and other medical instruments basedon the set of rules and a preference of the user; authenticating thesecond medical instrument based on an identifier associated with thesecond medical instrument using the processor; authenticating the userof the second medical instrument based on a password using theprocessor; generating a graphical representation of the second medicalinstrument; providing a set of rules associated with the second medicalinstrument based on the identifier associated with the second medicalinstrument and the user generating a second custom mode of operation ofthe second medical instrument based on a response of the user; creatinga name associated with the second custom mode of operation;automatically programming the second medical instrument based on thesecond custom mode; sharing the second custom mode with other users andother medical instruments based on the set of rules and a preference ofthe user.
 4. The method of claim 1, further comprising: applying thefirst soliton wave and the second soliton wave every other day up tosixty days.